BAJAJ BROKING

Notification
No new Notification messages
Nisus Finance Services IPO is Open!
Apply for the Nisus Finance Services IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
ang lifesciences india limited stock

ANG Lifesciences India Limited Share Price

46.7 -1.27 (-2.64%)
Dec 04 2024 03:29 PM Pharmaceuticals NSE: ANG

ANG Lifesciences India Limited Share Price Update

As of the latest trading session, ANG Lifesciences India Limited share price is currently at 46.7, which is down by -1.27 from its previous closing. Today, the stock has fluctuated between 45.67 and 49.98. Over the past year, ANG Lifesciences India Limited has achieved a return of -25.83 %. In the last month alone, the return has been 1.50 %. Read More...

ANG Lifesciences India Limited Performance

Day Range

Low45.67 High49.98
46.12

52 Week Range

Low 43.00 High 86.06
46.12

ANG Lifesciences India Limited Share Price

540694

ANG

img img img img
No Data Available

Open Price

47.90

Prev. Close

47.98

Volume (Shares)

33136.00

Total traded value

15.51

Upper Circuit

50.37

Lower Circuit

45.59

Note: The current prices & values are delayed, Login to your account for live updates.

ANG Lifesciences India Limited Fundamentals


(Standalone)

Market Cap (Cr) 60.98
PE Ratio (TTM) -5.20
Book Value / Share 56.15
Beta 0.16
ROE -8.72%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -1.07

ANG Lifesciences India Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 32.16
Operating Expense 33.19
Net Profit -1.07
Net Profit Margin (%) -3.32
Earnings Per Share (EPS) -0.75
EBITDA 2.82
Effective Tax Rate (%) -61.19
Particulars JUN 2024 (Values in Cr)
Revenue 16.18
Operating Expense 21.28
Net Profit -2.77
Net Profit Margin (%) -17.11
Earnings Per Share (EPS) -2.12
EBITDA -0.57
Effective Tax Rate (%) 26.13
Particulars MAR 2024 (Values in Cr)
Revenue 34.08
Operating Expense 35.51
Net Profit -3.60
Net Profit Margin (%) -10.56
Earnings Per Share (EPS) -2.73
EBITDA 2.36
Effective Tax Rate (%) -23.71
Particulars DEC 2023 (Values in Cr)
Revenue 17.10
Operating Expense 22.81
Net Profit -4.59
Net Profit Margin (%) -26.84
Earnings Per Share (EPS) -3.51
EBITDA -1.81
Effective Tax Rate (%) 21.13
Particulars SEP 2023 (Values in Cr)
Revenue 29.58
Operating Expense 32.19
Net Profit -2.05
Net Profit Margin (%) -6.93
Earnings Per Share (EPS) -1.53
EBITDA 1.65
Effective Tax Rate (%) 10.08
Particulars MAR 2024 (Values in Cr)
Revenue 131.37
Operating Expense 139.34
Net Profit -8.65
Net Profit Margin (%) -6.58
Earnings Per Share (EPS) -6.48
EBITDA 8.21
Effective Tax Rate (%) 2.48
Particulars MAR 2023 (Values in Cr)
Revenue 207.01
Operating Expense 214.76
Net Profit -0.66
Net Profit Margin (%) -0.31
Earnings Per Share (EPS) 0.04
EBITDA 20.91
Effective Tax Rate (%) 131.88
Particulars MAR 2022 (Values in Cr)
Revenue 348.67
Operating Expense 296.56
Net Profit 39.71
Net Profit Margin (%) 11.38
Earnings Per Share (EPS) 38.51
EBITDA 66.03
Effective Tax Rate (%) 25.16
Particulars MAR 2021 (Values in Cr)
Revenue 154.28
Operating Expense 145.16
Net Profit 7.25
Net Profit Margin (%) 4.69
Earnings Per Share (EPS) 12.63
EBITDA 15.68
Effective Tax Rate (%) 26.47
Particulars MAR 2020 (Values in Cr)
Revenue 126.83
Operating Expense 118.85
Net Profit 6.10
Net Profit Margin (%) 4.80
Earnings Per Share (EPS) 11.76
EBITDA 12.51
Effective Tax Rate (%) 27.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.82
ROE % -10.56
ROCE % 1.43
Total Debt to Total Equity 0.88
EBITDA Margin 7.28
Particulars MAR 2023 (Values in Cr)
Book Value / Share 62.43
ROE % -0.21
ROCE % 8.31
Total Debt to Total Equity 0.87
EBITDA Margin 10.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 76.28
ROE % 48.13
ROCE % 35.05
Total Debt to Total Equity 0.92
EBITDA Margin 19.42
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.74
ROE % -8.72
ROCE % 1.71
Total Debt to Total Equity 0.71
EBITDA Margin 7.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 61.91
ROE % -0.46
ROCE % 7.81
Total Debt to Total Equity 0.69
EBITDA Margin 9.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 76.00
ROE % 63.62
ROCE % 49.10
Total Debt to Total Equity 0.83
EBITDA Margin 19.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 76.99
ROE % 19.10
ROCE % 19.05
Total Debt to Total Equity 0.83
EBITDA Margin 10.42
Particulars MAR 2020 (Values in Cr)
Book Value / Share 66.67
ROE % 19.27
ROCE % 20.74
Total Debt to Total Equity 0.67
EBITDA Margin 10.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.73
Total Assets 242.43
Total Liabilities 242.43
Total Equity 76.27
Share Outstanding 13058287
Price to Book Ratio 0.77
Return on Assets (%) -4.18
Return on Capital (%) -6.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.17
Total Assets 277.66
Total Liabilities 277.66
Total Equity 86.21
Share Outstanding 13058287
Price to Book Ratio 1.23
Return on Assets (%) -0.09
Return on Capital (%) -0.17
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.65
Total Assets 291.03
Total Liabilities 291.03
Total Equity 83.76
Share Outstanding 10366630
Price to Book Ratio 3.09
Return on Assets (%) 13.85
Return on Capital (%) 25.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.49
Total Assets 217.42
Total Liabilities 217.42
Total Equity 77.07
Share Outstanding 13058287
Price to Book Ratio 0.77
Return on Assets (%) -3.97
Return on Capital (%) -6.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.05
Total Assets 252.50
Total Liabilities 252.50
Total Equity 85.53
Share Outstanding 13058287
Price to Book Ratio 1.23
Return on Assets (%) -0.26
Return on Capital (%) -0.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.58
Total Assets 268.68
Total Liabilities 268.68
Total Equity 83.48
Share Outstanding 10366630
Price to Book Ratio 3.09
Return on Assets (%) 14.78
Return on Capital (%) 27.49
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 142.24
Total Liabilities 142.24
Total Equity 41.35
Share Outstanding 5183315
Price to Book Ratio 1.11
Return on Assets (%) 5.09
Return on Capital (%) 8.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.60
Total Assets 94.07
Total Liabilities 94.07
Total Equity 34.55
Share Outstanding 5183315
Price to Book Ratio 0.45
Return on Assets (%) 6.47
Return on Capital (%) 11.56
Particulars MAR 2024 (Values in Cr)
Net Income -10.71
Cash from Operations 3.91
Cash from Investing 19.89
Cash from Financing -10.40
Net change in Cash 0.00
Free Cash Flow 9.48
Particulars MAR 2023 (Values in Cr)
Net Income 2.62
Cash from Operations 29.83
Cash from Investing -9.32
Cash from Financing -17.07
Net change in Cash -0.02
Free Cash Flow 40.28
Particulars MAR 2022 (Values in Cr)
Net Income 53.50
Cash from Operations 25.24
Cash from Investing -44.40
Cash from Financing 19.92
Net change in Cash 0.23
Free Cash Flow 66.58
Particulars MAR 2024 (Values in Cr)
Net Income -8.86
Cash from Operations 0.26
Cash from Investing 20.01
Cash from Financing -7.00
Net change in Cash -0.11
Free Cash Flow 5.70
Particulars MAR 2023 (Values in Cr)
Net Income 2.06
Cash from Operations 29.36
Cash from Investing -9.34
Cash from Financing -16.74
Net change in Cash -0.08
Free Cash Flow 39.80
Particulars MAR 2022 (Values in Cr)
Net Income 53.06
Cash from Operations 27.97
Cash from Investing -42.50
Cash from Financing 15.28
Net change in Cash 0.17
Free Cash Flow 67.31
Particulars MAR 2021 (Values in Cr)
Net Income 9.86
Cash from Operations -10.55
Cash from Investing -7.78
Cash from Financing 18.80
Net change in Cash -0.16
Free Cash Flow -6.48
Particulars MAR 2020 (Values in Cr)
Net Income 6.09
Cash from Operations 7.48
Cash from Investing -1.65
Cash from Financing -3.94
Net change in Cash -0.77
Free Cash Flow 9.12
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 33.57 3.18 447.69 37.54 / 77.70
BLISS GVS PHARMA LTD 163.60 20.48 1.70 1722.74 92.25 / 172.40
CIPLA LTD 1534.40 26.84 4.36 123920.06 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.85 141.27 4.12 1197.40 145.00 / 413.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 50.80 9.93 447.69 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.60 45.60 7.27 2167.14 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6597.95 128.14 24.28 16494.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 163.60 21.30 1.68 1722.74 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 46.50
  • 26 Days 45.90
  • 10 Days 45.90
  • 50 Days 47.50
  • 12 Days 45.80
  • 100 Days 48.80
  • 20 Days 45.90
  • 200 Days 64.80
46.08
PIVOT
First Resistance 47.17
Second Resistance 48.08
Third Resistance 49.17
First Support 45.17
Second Support 44.08
Third Support 43.17
RSI 59.71
MACD -0.07
Commodity Channel Index (CCI) 144.72
ADX 21.77
Williams % R -1.78

Over 1 Month

down

1.50

Over 3 Months

down

-1.01

Over 6 Months

down

-7.92

Over 1 Year

down

-25.83

Over 3 Years

down

-52.17

Over 5 Years

down

22.21

ANG Lifesciences India Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ANG Lifesciences India Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
-15.48
Promoter Holdings
70.6
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
44.88
Name Category Shares Shares%
Rajesh Gupta Shareholding of Promoter and Promoter Group 9194537.0 70.41
Rajeev Sivasankara Pillai Public Shareholding 135060.0 1.03
Saruchi Gupta Shareholding of Promoter and Promoter Group 25000.0 0.19

ANG Lifesciences India Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2021-11-02 1.0 Interim 2021-11-04 Equity shares
Ex-Date Ex-Bonus Ratio
2022-07-14 2022-07-13 1:4 2021-09-23 2021-09-22 1:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ANG Lifesciences India Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ANG Lifesciences India Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of ANG Lifesciences India Ltd?

Answer Field

The share price of ANG Lifesciences India Ltd for NSE is ₹ 0.00 and for BSE is ₹ 46.12.

What is the Market Cap of ANG Lifesciences India Ltd?

Answer Field

The market cap of ANG Lifesciences India Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 60.20 Cr. as of now.

What is the 52 Week High and Low of ANG Lifesciences India Ltd?

Answer Field

The 52 Week High and Low of ANG Lifesciences India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 86.06 and ₹ 43.00.

How to Buy ANG Lifesciences India Ltd share?

Answer Field

You can trade in ANG Lifesciences India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for ANG Lifesciences India Ltd?

Answer Field

The 1 year returns on the stock has been -25.83%.

What is the Current Share Price of ANG Lifesciences India Ltd?

Answer Field

ANG Lifesciences India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 46.12 as on Dec 04 2024 03:29 PM.

What is the Market Cap of ANG Lifesciences India Ltd Share?

Answer Field

The market cap of ANG Lifesciences India Ltd for NSE ₹ 0.0 & for BSE ₹ 60.20 as on Dec 04 2024 03:29 PM.

What is the P/E Ratio of ANG Lifesciences India Ltd Share?

Answer Field

As on Dec 04 2024 03:29 PM the price-to-earnings (PE) ratio for ANG Lifesciences India Ltd share is -5.20.

What is the PB ratio of ANG Lifesciences India Ltd Share?

Answer Field

As on Dec 04 2024 03:29 PM, the price-to-book (PB) ratio for ANG Lifesciences India Ltd share is 56.15.

How to Buy ANG Lifesciences India Ltd Share?

Answer Field

You can trade in ANG Lifesciences India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy ANG Lifesciences India Ltd Share on Bajaj Broking App?

Answer Field

To buy ANG Lifesciences India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “ANG Lifesciences India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader